RxDoctor Payments Data

Klitos Konstantinidis, MD

Clinical Cardiac Electrophysiology · Baltimore, MDNPI 1922373026

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (59.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Medtronic at 60.0% of the total. Reporting peaked in 2019 at $13,641 and has fallen 93.2% since, to $928 in 2025.

$23,838in general payments, 2019–2025

Across 90 payments — averaging $264.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$14K
  • Abbott$6K
  • Boston Scientific$3K
  • Biosense Webster, Inc.$962
  • Cardiva Medical, Inc.$18
$46,337in research payments, 2019–2025

Across 20 payments — averaging $2316.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$46K

What the payments were for

  • Grants$14,20860%
  • Travel & lodging$5,83024%
  • Food & beverage$3,37914%
  • Education$4202%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)31$14,303
Abbott41$6,012
Boston Scientific7$2,544
Biosense Webster, Inc.10$962
Cardiva Medical, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,838 in reported general payments places this provider in the 70th percentile of 63 clinical cardiac electrophysiology providers in Maryland.

See all clinical cardiac electrophysiology providers in Maryland

Medicare billing

Part B allowed, 2024
$140,268
Medicare patients
1,541
Services billed
2,372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$35,201
Flecainide Acetate27$901
Metoprolol Succinate15$182

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →